Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2023 Mar 30;14:1176102. doi: 10.3389/fendo.2023.1176102

Corrigendum: C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis

Kechong Zhou 1,†, Chao Li 2,†, Tao Chen 1, Xuejun Zhang 1, Baoluo Ma 1,*
PMCID: PMC10111613  PMID: 37082133

Text correction

In the published article, there was an error. There was a mistake in the Abstract. The result of cancer-specific survival (CSS) was displayed as “HR = 1.663, 95%CI = 1.064-2.6, P = 0.026”.

A correction has been made to the Abstract, Paragraph 1. This sentence previously stated:

“[HR = 1.663, 95%CI = 1.064-2.6, P = 0.026]”

The corrected sentence appears below:

“[HR =1.823, 95%CI = 1.19-2.793, P = 0.006]”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES